Tumor-Educated Platelets (TEPs) reprogram the behavior of CTCs via a direct interaction accompanied by exchanging RNA, lipids, and proteins (i.e., beta-3 integrin marker CD61) [206]. This evidence concerns the gene ITGB3 and neoplasm.